Patent Number: 6,251,402

Title: Use of human chorionic gonadotropin in the treatment of Kaposi's sarcoma

Abstract: The use of hCG Beta-core or hCG fragments, deglycosylated hCG in the treatment of Kaposi's sarcoma is described. Inhibition of tumor production or regression on a variety of KS cell lines is shown. Purified hCG preparations do not inhibit the growth of KS cell lines.

Inventors: Schwarz; Siegfried (Innsbruck, AT)

Assignee: Applied Research Systems ARS Holding N.V.

International Classification: A61K 38/24 (20060101); A61K 039/00 (); C07K 014/59 ()

Expiration Date: 06/26/2018